Warrant Issuances Sample Clauses
The Warrant Issuances clause defines the terms and conditions under which a company may issue warrants, which are financial instruments granting the holder the right to purchase shares at a specified price within a certain timeframe. This clause typically outlines the number of warrants to be issued, the exercise price, the vesting schedule, and any conditions or events that may trigger the issuance. By clearly specifying these details, the clause ensures both parties understand the circumstances and mechanics of warrant issuance, thereby reducing ambiguity and potential disputes regarding future equity rights.
Warrant Issuances. The Company will issue to Buyer or its ----------------- designee within five (5) days after any conversion of Preferred Shares a Warrant in substantially the form of Exhibit C attached hereto, to acquire one share of Common Stock for each three Conversion Shares that are issued on such conversion of Preferred Shares, with an exercise price equal to the lower $7.15 per share and 110 percent of the Average Market Price (as that term is defined in Exhibit A hereto) per share of Common Stock for the five trading days preceding such conversion. Each Warrant shall expire to the extent not exercised on the third anniversary of the date of the relevant conversion.
Warrant Issuances. At Closing, the Company shall issue to each Buyer warrants to acquire 33,334 shares of Common Stock for each one million dollars ($1,000,000) invested in the form as attached as Exhibit "C" hereto. The Company shall, in addition to the Warrants otherwise issuable hereunder, issue to each Buyer such Warrants (the "LOCK-UP WARRANTS") as may be issuable to a Buyer pursuant to Section 2(i) of the Certificate of Designations. Each Warrant issued hereunder (including pursuant to Section 2(i) of the Certificate of Designations) shall be immediately exercisable and shall expire (to the extent not exercised) on the fifth (5th) anniversary of its issuance date.
Warrant Issuances. Subject to the satisfaction of the terms and condition of this Agreement, May ▇▇▇▇▇ Group, Inc., as the Placement Agent will receive on the Closing Date warrants ("Convertible Warrants") to purchase 500,000 shares of Common Stock (the "Convertible Warrant Shares") at an exercise price of Three Dollars ($3.00) per share. The Warrants shall be exercisable for a period of five (5) years from the date of issuance and shall be substantially in the form of the form of Warrant hereto as Exhibit D.
Warrant Issuances. In the event the Company, one time or from time to time, issues any warrants or options to purchase capital stock of the Company after the date hereof (the “New Warrants”), then the Company shall issue to the Anti-Dilution Rights Holders a number of Warrants or options, on identical terms to the New Warrants, equal to the result of the following formula: number of shares issuable upon exercise of such warrants or options issued in such issuance, multiplied by (total shares of Common Stock and warrants owned by such Anti-Dilution Rights Holder on the date of such issuance divided by total shares of Common Stock outstanding on the date of such issuance). Notwithstanding anything herein to the contrary, in the event by operation of this paragraph an issuance would cause the Anti-Dilution Rights Holder to hold five percent (5%) or more of the issued and outstanding Common Stock of the Company, then a provision shall be added to any warrants or options issued providing that the warrant or option may not be exercised to the extent such exercise would cause the holder of such warrant or option to beneficially own five percent or more of the outstanding common stock of the Company; provided further, that the expiration date of any such warrant or option would be extended to the date which is ten business days after the exercise of the entire warrant or option would not cause such holder to beneficially own five percent or more of the outstanding common stock of the Company.
Warrant Issuances. At the Initial Closing, the Company will issue to Buyer a Warrant duly executed on behalf of the Company, substantially in the form of Exhibit A attached hereto, to acquire the Warrant Shares at an exercise price per Warrant Share equal to the per share price for the Shares (subject to adjustment in the manner set forth in the Warrant), which Warrant may be exercised as follows: (i) during the twelve (12) month period commencing on the Initial Closing Date and ending on the date which is twelve (12) months after the Initial Closing Date (the "First Warrant Period"), Buyer shall be entitled to purchase up to the full amount of the Warrant Shares (i.e., 2,000,000 shares) at the Per Share Price; and (ii) during the period commencing twelve (12) months after the Initial Closing Date and ending twenty-four (24) months after the Initial Closing Date (the "Second Warrant Period"), and provided that Buyer acquired at least 1,000,000 of the Warrant Shares during the First Warrant Period, Buyer shall be entitled to purchase all Warrant Shares not purchased during the First Warrant Period.
Warrant Issuances. The Parent Guarantor agrees to (a) as soon as practicable on June 11, 2024, file the amendment to the Parent Guarantor’s Second Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada to increase the number of shares of Common Stock authorized for issuance thereunder from 166,666,667 to 300,000,000, (b) on or prior to June 17, 2024, issue a warrant to the Warrant Holder in respect of 6,300,449 shares of Common Stock of the Parent Guarantor in a registered offering under the Securities Act, including providing the deliverables set forth in Part III of Annex E to the Note, (c) issue 2,964,917 shares of Common Stock of the Parent Guarantor on the earlier of (1) the date that the Final $40 Million Committed Amount is extended and (2) the date the Final Warrant Issuance Conditions are (x) satisfied or (y) waived by the in accordance with Section 2.1(a)(ii)(B) of the Note and (d) in the event the accordion (as described in the Term Sheet) is funded, substantially concurrently with such funding issue an additional warrant to the Warrant Holders in respect of 5,559,220 shares of Common Stock of the Parent Guarantor, including providing the deliverables set forth in Part III of Annex E of the Note.
Warrant Issuances. The Company will issue the following warrants, in the form attached hereto as Exhibit B:
Warrant Issuances. At Closing, the Company shall cause to be issued to each Buyer warrants to acquire 50,000 shares of common stock, par value $.001 of its majority owned subsidiary Electronic Medical Distribution, Inc. for each one million dollars ($1,000,000) invested in the form as attached as Exhibit "C" hereto (the "EMD WARRANTS").
Warrant Issuances. Parent and the Investors agree that from and after the Closing, Company may issue debt to third parties with attached warrants to purchase an aggregate amount of the Company's Common Stock equal to up to five percent (5%) of the total outstanding shares of Common Stock of the Company, calculated on a fully diluted basis, at the time of such issuance.
Warrant Issuances. As of the Effective Time and subject to the satisfaction (or waiver) of the conditions set forth in Section 5 and 6 below, the Company and the Holder hereby agree that each Holder and each Other Holder shall be issued Warrants, in substantially the form attached hereto as Exhibit B (the “Amendment Warrants”), representing the right to acquire 4 shares of Common Stock for each $10 aggregate principal amount of Notes to be amended and restated pursuant to this Agreement.